Skip to main content

Table 1 Propagation and differentiation of HES3 to cardiomyocytes using different culture methods

From: Conjoint propagation and differentiation of human embryonic stem cells to cardiomyocytes in a defined microcarrier spinner culture

Culture conditions

MNL hESC cultures

hESC/MC aggregate spinner cultures

Propagation (7 days)

Expansion fold (propagation)

10.3 ± 0.4

15.4 ± 0.4

% Pluripotent cells

  

Tra-1-60-positive

93.1 ± 1.4

96.2 ± 1.7

mAb84-positive

99.4 ± 0.5

98.6 ± 1.7

Aggregate sizes (μm)

NA

316 ± 11

Differentiation to cardiomyocytes (20 days)

 

MNL

MC-Rp

MC-SS

MC-AS

MC-Sp

Expansion fold (differentiation)

2.0 ± 0.2

2.2 ± 0.1

2.1 ± 0.2

2.0 ± 0.2

2.3 ± 0.1

% beating aggregates

Beating sheet

65.7 ± 1.8 (beating foci on plate)

66.5 ± 2.6

53.4 ± 1.5

73.6 ± 2.8

Beating aggregate size (μm)

NA

NA

1063 ± 53

581 ± 54

655 ± 13

% Cardiomyocytes

     

MHC-positive

45.7 ± 4.6

43.1 ± 1.2

42.6 ± 1.9

42.8 ± 1.6

47.7 ± 1.9

cTnT-positive

51.1 ± 0.5

53.1 ± 0.9

45.7 ± 2.9

42.4 ± 0.2

56.1 ± 1.4

CM/hESC

3.8 ± 0.2

1.2 ± 0.2

1.0 ± 0.2

0.8 ± 0.1

9.6 ± 0.3a

CM/ml (×x106)

0.5 ± 0.02

0.2 ± 0.02

0.1 ± 0.02

0.1 ± 0.01

1.9 ± 0.05b

Total expansion fold (propagation + differentiation)

20.0 ± 0.8

32.8 ± 1.1

31.8 ± 2.1

29.3 ± 2.5

34.3 ± 0.9c

  1. HES3 cells were propagated as either monolayer cultures (MNL) or human embryonic stem cell (hESC)/microcarrier (MC) aggregates for 7 days. Five differentiation culture regimes were tested. Data presented are mean ± standard deviation (n = 3 to 4). In HES3 cultures: asignificant difference between MC-Sp and MNL (P < 0.05), and between MC-Sp and the other three regimes (P < 0.01), in terms of cardiomyocytes produced per initial hESC seeded (CM/hESC); bsignificant differences (P < 0.01) between MC-Sp and the other four regimes in terms of cardiomyocyte density (CM/ml); csignificant difference between MC-Sp and MNL (P < 0.05) in terms of total expansion fold achieved. CM, number of cardiomyocytes (cTnT-positive cells) in the final cell population; Total expansion fold, cell expansion from seeding the hESC culture in the propagation phase, to final CM harvesting (day 20) in the differentiation phase. cTnT, Cardiac troponin T; MC-AS, hESC/MC aggregates in agitated suspension cultures; MC-Rp, monolayer replated cultures; MC-Sp, hESC/MC aggregates in spinner cultures; MC-SS, hESC/MC aggregates in static suspension cultures; MHC, myosin heavy chain; NA, not available.